
zzso is a zzso zzso zzso for the zzso growth factor zzso zzso that may provide benefit to select cancer zzso however, identification of the characteristics of those patients who may benefit from its use is not zzso The zzso drug response marker zzso is an in zzso zzso that can provide drug response data on tumor specimens before any patient treatment is zzso We determined the feasibility of using the zzso zzso to test tumor samples for sensitivity to zzso We exposed four zzso cell lung zzso zzso cell lines zzso zzso zzso and zzso to zzso and determined their sensitivity using the zzso zzso and, in zzso zzso status using zzso Western zzso and zzso Western zzso zzso We used the zzso zzso to determine zzso sensitivity of primary zzso and zzso tumor zzso The zzso zzso distinguished between zzso and zzso cell zzso zzso sensitivity was not dependent on zzso zzso zzso zzso cells were zzso to zzso yet contain zzso zzso whereas zzso cells were zzso responsive to zzso and contain zzso zzso zzso zzso cells were zzso responsive and, as expected, zzso cells zzso were zzso to zzso zzso zzso sensitivity of primary zzso and zzso tumor samples was zzso and zzso zzso Use of the zzso zzso is feasible for determining zzso zzso The zzso zzso responses of primary zzso and zzso tumor specimens were similar to published response rates of patients to treatment with zzso zzso 

